Crescent Capital BDC (NASDAQ:CCAP) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) released its quarterly earnings data on Wednesday. The company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.56 by ($0.01), Zacks reports. The firm had revenue of $46.40 million for the quarter, compared to analysts’ expectations of $47.27 million. Crescent Capital BDC had a return on equity of 11.86% and a net margin of 37.32%.

Crescent Capital BDC Trading Down 4.7 %

Shares of CCAP opened at $19.06 on Friday. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14. The firm’s 50-day moving average is $19.46 and its two-hundred day moving average is $18.86. Crescent Capital BDC has a twelve month low of $16.38 and a twelve month high of $20.19. The firm has a market capitalization of $706.33 million, a P/E ratio of 9.58 and a beta of 0.81.

Crescent Capital BDC Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.42 per share. The ex-dividend date is Monday, March 31st. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.81%. Crescent Capital BDC’s dividend payout ratio (DPR) is 84.42%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on CCAP shares. Keefe, Bruyette & Woods boosted their price target on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Monday, November 25th. Wells Fargo & Company boosted their price target on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 29th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Crescent Capital BDC currently has a consensus rating of “Moderate Buy” and an average target price of $19.33.

Get Our Latest Report on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.